首页> 外文期刊>Cureus. >Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report
【24h】

Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report

机译:卡培他滨放化疗继发生殖器累及手掌-性红斑感觉异常:一例报告

获取原文
           

摘要

Palmar-plantar erythrodysesthesia (PPE) is a common dermatologic adverse reaction secondary to capecitabine use, but the skin toxicity rarely involves the genitals. We describe a case of PPE with scrotal and penile involvement secondary to capecitabine chemotherapy concurrent with radiotherapy. The patient presented with pain and erythema involving the penis and scrotum during the fifth week of neoadjuvant chemoradiotherapy with capecitabine for T3c N2b M0 low rectal adenocarcinoma. The onset and severity of symptoms in the genitals were loosely associated with the symptoms in the hands and feet. The pain and erythema were self-limiting and improved 11 days after capecitabine discontinuation and local supportive care.
机译:手掌-性红斑感觉不良(PPE)是卡培他滨继发的常见皮肤病学不良反应,但皮肤毒性很少涉及生殖器。我们描述了卡培他滨化疗伴放疗继发阴囊和阴茎受累的PPE病例。在卡培他滨新辅助化疗放疗的第五周,T3c N2b M0低位直肠腺癌患者出现阴茎和阴囊疼痛和红斑。生殖器症状的发作和严重程度与手和脚的症状松散相关。疼痛和红斑是自限性的,在停用卡培他滨和局部支持治疗后11天有所改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号